Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)
South Korea · Delayed Price · Currency is KRW 2,195.00
+50.00 (2.33%)
At close: Aug 20, 2026
Kookjeon Pharmaceutical Market Cap
Kookjeon Pharmaceutical has a market cap or net worth of 118.5 billion as of August 20, 2026. Its market cap has decreased by -40.11% in one year.
Market Cap
118.50B
Enterprise Value
129.54B
Revenue
127.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,195.00
ChartMarket Cap Chart
Since December 16, 2020, Kookjeon Pharmaceutical's market cap has increased from 37.63B to 118.50B, an increase of 214.95%. That is a compound annual growth rate of 22.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 118.50B | -29.82% |
| Dec 30, 2025 | 168.84B | -2.11% |
| Dec 30, 2024 | 172.48B | -43.67% |
| Dec 28, 2023 | 306.19B | -5.74% |
| Dec 29, 2022 | 324.84B | -39.54% |
| Dec 30, 2021 | 537.31B | 40.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pureun Savings Bank | 120.11B |
| KCC Engineering & Construction | 119.84B |
| Nine & Company | 119.61B |
| FarmStory | 119.56B |
| ViGenCell | 119.10B |
| Avatec | 119.05B |
| KX Innovation | 118.67B |
| Hyundai Ezwel | 118.46B |